Underwriting AgreementUnderwriting Agreement • November 1st, 2024 • Synovus Financial Corp • National commercial banks • New York
Contract Type FiledNovember 1st, 2024 Company Industry JurisdictionSynovus Financial Corp., a Georgia corporation (the “Company”), confirms its agreement with BofA Securities, Inc. and Morgan Stanley & Co. LLC (together, the “Representatives”) on behalf of the several Underwriters listed in Schedule I hereto (together, the “Underwriters”), with respect to the issue and sale by the Company, and the purchase by the Underwriters, acting severally and not jointly, of the respective principal amounts set forth in Schedule I of $500,000,000 in aggregate principal amount of the Company’s 6.168% Fixed Rate / Floating Rate Senior Notes due 2030 (the “Securities”). The Securities are to be issued pursuant to an indenture, dated as of February 13, 2012 (the “Indenture”), by and between the Company and the Bank of New York Mellon Trust Company, N.A., as trustee.
MOLECULAR PARTNERS AG 3,642,988 American Depositary Shares, representing 3,642,988 Ordinary Shares Underwriting AgreementUnderwriting Agreement • October 28th, 2024 • Molecular Partners Ag • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 28th, 2024 Company Industry Jurisdiction
ContractUnderwriting Agreement • August 5th, 2022 • Synovus Financial Corp • National commercial banks • New York
Contract Type FiledAugust 5th, 2022 Company Industry Jurisdiction